Search results for "Cytotoxic"

showing 10 items of 1673 documents

Immunological and biological identification of tumour necrosis-like factor in sponges: Endotoxin that mediates necrosis formation in xenografts

1992

Xenografts of the sponge Geodia cydonium in its closely related species G. rovinjensis resulted in a rapid rejection of the graft within a period of 5 days. We identified an immunoreactive tumour necrosis factor (TNF)-like activity in the xenograft (Mr of 30,000) two days after grafting. In-vivo injection of 5 micrograms human recombinant TNF-alpha induced cytotoxicity in sponge cells in the same pattern and time course as during natural xenograft rejection. Anti-TNF-alpha polyclonals were found to react with xenograft extracts, by Western blot analysis, as from day 2 after grafting. Using ELISA we detected the TNF-like activity from day 2 after grafting with peak levels at days 4 and 5, wh…

Interferon InducersNecrosisTransplantation HeterologousImmunologyEnzyme-Linked Immunosorbent AssayBiochemistryInjectionslaw.inventionNecrosisWestern blotlawmedicineAnimalsImmunology and AllergyCytotoxicityReceptorMolecular BiologyGlycoproteinsCell Deathbiologymedicine.diagnostic_testTumor Necrosis Factor-alphaLectinHematologybiology.organism_classificationMolecular biologyExtracellular MatrixPoriferaEndotoxinsMolecular WeightSpongeImmunologybiology.proteinRecombinant DNATumor necrosis factor alphamedicine.symptomCytokine
researchProduct

Estimation of the frequency of self-reactive T cells in health and inflammatory diseases by limiting dilution analysis and single cell cloning.

1996

Autoreactive T cells have recently been detected not only in autoimmune diseases but also in healthy individuals, but their frequency is thought to be low. The aim of our study was to estimate the frequency of self-reactive T cells by using limiting dilution analyses of peripheral blood lymphocytes. Assessment of self-reactivity in this study was defined as T-cell proliferation to autologous non-T cells in the absence of foreign antigens. When culture conditions were optimized by adding interleukin 2, healthy individuals showed a frequency of self-reactive T cells ranging from 1/60 to 1/600. These results were confirmed by using unseparated peripheral blood leukocytes or Epstein-Barr virus …

Interleukin 2AdultMaleAdolescentmedicine.medical_treatmentT-LymphocytesImmunologyInterleukin 21AntigenmedicineImmunology and AllergyCytotoxic T cellHumansLymphocyte CountInflammationbiologybusiness.industryT lymphocyteMiddle AgedClone CellsCytokineImmunologyInterleukin 12biology.proteinInterleukin-2FemaleInterleukin-4Antibodybusinessmedicine.drugJournal of autoimmunity
researchProduct

Endothelial Nitric Oxide Synthase Regulates T Cell Receptor Signaling at the Immunological Synapse

2006

The role of nitric oxide (NO) in T cells remains controversial, and the origin and localization of endogenous NO and whether it regulates lymphocyte activation are unclear. We show here that, within minutes of binding to antigen, T cells produce NO via endothelial nitric oxide synthase (eNOS). This process required increased intracellular Ca2+ and phosphoinositide3-kinase activity. By using an eNOS-green fluorescent fusion protein and fluorescent probes to detect NO, we show that eNOS translocates with the Golgi apparatus to the immune synapse of T helper cells engaged with antigen-presenting cells (APC), where it was fully activated. Overexpression of eNOS prevented the central coalescence…

Interleukin 2CD3 ComplexNitric Oxide Synthase Type IIIT-LymphocytesImmunologyReceptors Antigen T-CellAntigen-Presenting CellsGolgi ApparatusBiologyLymphocyte ActivationNitric OxideNitric oxideImmunological synapseInterferon-gammaMicePhosphatidylinositol 3-Kinaseschemistry.chemical_compoundAntigenmedicineAnimalsHumansImmunology and AllergyCytotoxic T cellAntigensMOLIMMUNOAntigen-presenting cellNitric Oxide Synthase Type IIIMice Mutant StrainsCell biologyInfectious DiseaseschemistryInterleukin-2CalciumSignal transductionSignal Transductionmedicine.drugImmunity
researchProduct

Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.

2006

AbstractAllogeneic cell therapy as a means to break immunotolerance to solid tumors is increasingly used for cancer treatment. To investigate cellular alloimmune responses in a human tumor model, primary cultures were established from renal cell carcinoma (RCC) tissues of 56 patients. In three patients with stable RCC line and human leukocyte antigen (HLA)-identical sibling donor available, allogeneic and autologous RCC reactivities were compared using mixed lymphocyte/tumor cell cultures (MLTC). Responding lymphocytes were exclusively CD8+ T cells, whereas CD4+ T cells or natural killer cells were never observed. Sibling MLTC populations showed higher proliferative and cytolytic antitumor …

Interleukin 2Cytotoxicity ImmunologicCancer ResearchCD3 ComplexCell SurvivalLymphocyteCD8 AntigensEnzyme-Linked Immunosorbent AssayHuman leukocyte antigenBiologyCD8-Positive T-LymphocytesLymphocytes Tumor-InfiltratingAntigenAntibody SpecificityHLA AntigensCell Line TumormedicineTumor Cells CulturedCytotoxic T cellHumansL-SelectinCarcinoma Renal CellCell ProliferationTumor-infiltrating lymphocytesSiblingsAntibodies MonoclonalFlow CytometryKidney NeoplasmsCTL*medicine.anatomical_structureOncologyImmunologyCD8medicine.drugT-Lymphocytes CytotoxicCancer research
researchProduct

IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-p)

1993

Experimental animal and human in vivo studies have previously demonstrated the impact of exogenous administration of various cytokines on frequencies of circulating myeloid and LAK precursor cells. For the first time we investigated whether exogenous cytokines, in the absence of antigenic challenge, may also influence frequencies of circulating antigen-specific cytotoxic T-lymphocyte precursor cells. We further asked whether triggering of autoimmune pathways as has been reported for several cytokines can be confirmed on the cellular level by demonstration of induction of autoreactive CTL-p. Limiting dilution analysis was used to determine alloreactive CTL-p frequencies in 31 patients with n…

Interleukin 2Stem Cellsmedicine.medical_treatmentClone (cell biology)Autoimmunityhemic and immune systemschemical and pharmacologic phenomenaHematologyGeneral MedicineBiologyRecombinant ProteinsInterferon-gammaCTL*CytokineImmunologymedicineSystemic administrationHumansInterleukin-2Cytotoxic T cellInterleukin-3Interferon gammaT-Lymphocytes CytotoxicInterleukin 3medicine.drugAnnals of Hematology
researchProduct

Gene Therapy of Human Melanoma — from Animal Experiments to the Clinical Trial

1997

Low immunogenecity of tumour cells is one of the reason that specific immune response is insufficient to destroy malignant cells. In an attempt to augment weakly immunogenic B78H1 mouse melanoma cell line, these cells were transfected with genomic DNA from a line of human melanoma cells expressing a 96kD melanoma associated antigen (MAA) that is intercellular adhesion molecule 1 (ICAM 1). The transfected cells expressed fivefold higher quantities of the melanoma associated antigen from which the DNA was obtained. Human ICAM 1 expressed by mouse melanoma cells appeared to be highly immunogenic leading to the rejection of the modified mouse melanoma cells. The transfected cells appeared to be…

Interleukin 2business.industryMelanomamedicine.diseaseAcquired immune systemImmune systemImmunophenotypingAntigenmedicineCancer researchCytotoxic T cellIL-2 receptorbusinessmedicine.drug
researchProduct

Maintenance and Function of Human CD8+ T Cells and NK Cells in Humanized Mice

2014

Human CD8+ T lymphocytes and NK cells can be successfully engrafted in highly immuno-deficient mouse strains such as NOD/shi-SCID/γgcnull (NOG), NOD/SCID/IL2Rγnull (NSG), NOD/Rag1KO/γcnull (NRG), and BALB/c-Rag2KO/γcnull (BRG) mice following reconstitution with human CD34+ hematopoietic stem cells (HSCs) or, alternatively, upon adoptive transfer of peripheral blood mononuclear cells (PBMC). These humanized immune system (HIS) mice have evolved as a promising tool to study human CD8+ T cell and NK cell-mediated immune responses to cancer and infectious diseases and to explore new approaches in adoptive immunotherapy and vaccination. However, long-term generation of CD8+ T lymphocytes and NK …

Interleukin 21Adoptive cell transfermedicine.anatomical_structureJanus kinase 3T cellImmunologyInterleukin 12medicineCytotoxic T cellIL-2 receptorBiologyAntigen-presenting cell
researchProduct

Tc9 cells, a new subset of CD8+T cells, support Th2-mediated airway inflammation

2013

Similar to T-helper (Th) cells, CD8(+) T cells also differentiate into distinct subpopulations. However, the existence of IL-9-producing CD8(+) T (Tc9) cells has not been elucidated so far. We show that murine CD8(+) T cells activated in the presence of IL-4 plus TGF-β develop into transient IL-9 producers characterized by specific IFN-γ and IL-10 expression patterns as well as by low cytotoxic function along with diminished expression of the CTL-associated transcription factors T-bet and Eomesodermin. Similarly to the CD4(+) counterpart, Tc9 cells required for their differentiation STAT6 and IRF4. Tc9 cells deficient for these master regulators displayed increased levels of Foxp3 that in t…

Interleukin 21CD40ImmunologyImmunologyInterleukin 12biology.proteinImmunology and AllergyCytotoxic T cellIL-2 receptorBiologyNatural killer T cellAntigen-presenting cellInterleukin 3European Journal of Immunology
researchProduct

Strong and sustained effector function of memory- versus naïve-derived T cells upon T-cell receptor RNA transfer: Implications for cellular therapy

2012

Current protocols used to select CMV-specific T cells for adoptive immunotherapy focus on virus-specific memory T cells from seropositive donors. However, this strategy is not feasible in patients undergoing allogeneic haematopoietic stem-cell transplantation (HSCT) from CMV-seronegative donors. Here, we redirected T cells of CMV-seronegative donors with a human genetically engineered TCR recognizing an HLA-A*0201-binding peptide epitope of CMVpp65. To facilitate clinical translation of this approach, we used a non-viral expression system based on in vitro transcribed RNA and electroporation. Although memory and naive-derived T-cell subsets were both efficiently transfected by TCR-RNA, memo…

Interleukin 21ZAP70ImmunologyImmunologyCancer researchImmunology and AllergyCD28Cytotoxic T cellIL-2 receptorStreptamerBiologyNatural killer T cellAntigen-presenting cellEuropean Journal of Immunology
researchProduct

BDCA1+ Dendritic Cells Drive The Differentiation Of Cytotoxic CD103+ Intraepithelial CD8+ T Cells In The Human Lung

2012

Interleukin 21medicine.anatomical_structureChemistryImmunologyCancer researchInterleukin 12medicineCytotoxic T cellAntigen-presenting cellHuman lungB14. CONTROL OF INNATE AND ADAPTIVE IMMUNITY IN THE LUNG
researchProduct